期刊
BIOMEDICAL CHROMATOGRAPHY
卷 33, 期 10, 页码 -出版社
WILEY
DOI: 10.1002/bmc.4621
关键词
atorvastatin; curcumin; HPLC; mouse; pharmacokinetics
类别
资金
- Fundacao para a Ciencia e a Tecnologia [CENTRO-01-0145-FEDER030752, POCI-01-0145-FEDER-016648, POCI-01-0145-FEDER-007440, Pest UID/NEU/04539/2013Pest-UID/NEU/04539/2013]
- COMPETE [POCI-01-0145-FEDER-007440, CENTRO-01-0145-FEDER-030752]
There is increasing interest in atorvastatin and curcumin owing to their potential anticancer activity. A new, accurate and sensitive HPLC method was developed, for the first time, to simultaneously quantify atorvastatin and curcumin in mouse plasma and brain, liver, lung and spleen tissues following protein precipitation sample preparation. The chromatographic separation was achieved in 13 min on a C-18 column, at 35 degrees C, using a mobile phase composed of acetonitrile-methanol-2% (v/v) acetic acid (37.5:2.5:60, v/v/v) at a flow rate of 1.0 mL/min. The detection of analytes and internal standard was carried out at 247, 425 and 250 nm, respectively. According to international guidelines, the method was shown to be selective, with lower limits of quantification ranging from 10 to 500 ng/mL for curcumin, and from 100 to 600 ng/mL for atorvastatin, linear over a wide concentration range (r(2) >= 0.9971) and with acceptable accuracy (bias +/- 12.29%) and precision (coefficient of variation <= 13.15%). The analytes were reproducibly recovered at a percentage >81.10% and demonstrated to be stable under various experimental conditions in all biological matrices. This method can be easily applied to in vivo biodistribution studies related to the intranasal administration of atorvastatin and curcumin, separately or simultaneously.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据